Time-Dependent Pharmacokinetics of 5-Fluorouracil and Association With Treatment Tolerability in the Adjuvant Setting of Colorectal Cancer-Reference-Cited by-同舟云学术

Time-Dependent Pharmacokinetics of 5-Fluorouracil and Association With Treatment Tolerability in the Adjuvant Setting of Colorectal Cancer

Published:2012-03 Issue:3 Volume:52 Page:361-369
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Ibrahim Toni,Di Paolo Antonello,Amatori Federica,Mercatali Laura,Ravaioli Elena,Flamini Emanuela,Sacanna Emanuele,Del Tacca Mario,Danesi Romano,Amadori Dino

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270010396710/fullpdf

Reference27 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation;Hind;Health Technol Assess,2008

3. Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer: a prospective randomized phase II study;Nakata;J Exp Clin Cancer Res,2007

4. Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patients;Paolo;Ther Drug Monit,2002

5. Oral uracil-tegafur plus leucovorin versus fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials [published online ahead of print December 28, 2009];Bin;Colorectal Dis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5‐Fluorouracil and Imidazole‐Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells;ChemMedChem;2023-02-24

2. Current status and future outlooks on therapeutic drug monitoring of fluorouracil;Expert Opinion on Drug Metabolism & Toxicology;2021-12-02

3. Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature;ESMO Open;2021-06

4. Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation;Journal of Enzyme Inhibition and Medicinal Chemistry;2021-01-01

5. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future;Pharmacology & Therapeutics;2020-02